MedPath
HSA Approval

OMJJARA FILM-COATED TABLET 200 MG

SIN17133P

OMJJARA FILM-COATED TABLET 200 MG

OMJJARA FILM-COATED TABLET 200 MG

November 1, 2024

GLAXOSMITHKLINE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGLAXOSMITHKLINE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

L01EJ04

Manufacturer Information

GLAXOSMITHKLINE PTE LTD

Patheon Inc.

Active Ingredients

Momelotinib Dihydrochloride Monohydrate eqv Momelotinib

200 mg

Momelotinib

Documents

Package Inserts

OMJJARA PI.pdf

Approved: November 1, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

OMJJARA FILM-COATED TABLET 200 MG - HSA Approval | MedPath